Sort
17,828 grants matching “crispr”
Enhancer for UCP1 transcription and thermogenesis
$578,060Hei Sook Sul · University Of California Berkeley · R01 · FY2024 · DK
Identification and Characterization of Loci Associated with Non-alcoholic Fatty Liver Disease
$578,049Nicholette D. Allred · Wake Forest University Health Sciences · R01 · FY2024 · DK
Combinatorial regulation of the enhancer codes in senescence
$577,975Michael G Rosenfeld · University Of California, San Diego · R01 · FY2019 · AG
Developing Autophagy-Targeting Chimeras and Optimizing Cell Penetration of Large-Molecule Therapeutics
$577,898Joshua A Kritzer · Tufts University Medford · R35 · FY2025 · GM
Cell Systems to Pre-Clinical Models
$577,785Yu Wang · University Of Michigan At Ann Arbor · U54 · FY2023 · NS
CRISPR-induced cardiovascular progenitor cells to repair myocardial infarction
$577,574Yigang Wang · University Of Cincinnati · R01 · FY2023 · HL
Uncovering treatment targets for peripheral nerve sheath tumor progression in NF1
$577,428David Andrew Largaespada · University Of Minnesota · R01 · FY2022 · NS
Tumor Suppressor Protein, p53
$577,282Ettore Appella · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Derivation of lung epithelia from iPS cells for advanced disease modeling
$577,162Darrell N. Kotton · Boston University Medical Campus · R01 · FY2025 · HL
PARP-1 as a novel target for alpha-particle therapy in high-risk Neuroblastoma
$577,080Daniel A. Pryma · University Of Pennsylvania · R01 · FY2022 · CA
The Genomic Architecture of Pregnancy Loss
$577,034Michael E Talkowski · Massachusetts General Hospital · R01 · FY2021 · HD
Project 1. Gene Variants and Their Interactions Defining Human NTD Risk
$577,017Margaret Elizabeth Ross · Weill Medical Coll Of Cornell Univ · P01 · FY2018 · HD
Using human iPSC derived microglia and chimeric models to examine the role of PLCG2 in Alzheimers disease
$576,849Hayk Davtyan · University Of California-Irvine · R01 · FY2020 · AG
Elucidating Protective Mechanisms for Cardiotoxicity of Kinase Inhibitors
$576,594Mark Mercola · Stanford University · P01 · FY2025 · HL
Spatiotemporal signaling and trafficking of the mu-opioid receptor
$576,534Ruth Huttenhain · Stanford University · R01 · FY2024 · DA
Modified neural stem cells for glycosylation-independent treatment of MPS IIIB
$576,498Michelina Iacovino · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R33 · FY2019 · NS
Developmental Functional Genomics in ASD Toddlers
$576,495Eric Courchesne · University Of California, San Diego · R01 · FY2020 · MH
Deciphering and disabling lysosome-dependent mechanisms of neurodegeneration
$576,185Roberto Zoncu · University Of California Berkeley · R01 · FY2025 · NS
The Investigation of disease causing genes in C. elegans
$576,181Andy Golden · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK
Multi-omic phenotyping of human transcriptional regulators
$576,097Sheng Li · Jackson Laboratory · U01 · FY2023 · HG
Development and Clinical Application of Gene and Cell therapies for Patients with Immune Deficiencies
$576,014Suk See De Ravin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Evolutionary Human Genomics: Demography, Natural Selection, and Transcriptional Regulation
$576,000Adam Charles Siepel · Cold Spring Harbor Laboratory · R35 · FY2024 · GM
Evolutionary Human Genomics: Demography, Natural Selection, and Transcriptional Regulation
$576,000Adam Charles Siepel · Cold Spring Harbor Laboratory · R35 · FY2025 · GM
Evolutionary Human Genomics: Demography, Natural Selection, and Transcriptional Regulation
$576,000Adam Charles Siepel · Cold Spring Harbor Laboratory · R35 · FY2023 · GM
Molecular Analysis of Developmental Brain Disorders Associated with Synaptic Pathology
$575,925Scott H Soderling · Duke University · R01 · FY2021 · MH